NZ's Truscreen soars on Vietnam's approval for commercial roll-out of cancer screening device

Truscreen

20/04/2020 02:29

** Shares of medical device maker Truscreen Ltd  TRU.NZ 
surge as much as 24.4% to NZ$0.107, in their biggest intraday
pct gain since July 2018
    ** Co gets approval from Vietnam's health ministry for the
commercial roll-out of its cervical cancer screening device
 urn:newsml:reuters.com:*:nFWN2C600A
    ** Adds approval is granted initially for the Hanoi
Obstetrics and Gynaecology Hospital and expects further
roll-outs across other public and private hospitals this year
    ** Stock hits its highest level since Jan. 31 and is poised
for a fifth straight session of gains 
    ** More than 485,700 shares change hands, compared with the
30-day average of 41,800 shares

 (Reporting by Shriya Ramakrishnan in Bengaluru)
 ((Shriya.Ramakrishnan@thomsonreuters.com;))